ClinicalTrials.Veeva

Menu

Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type

O

Odense University Hospital

Status and phase

Completed
Phase 4

Conditions

Hip Fracture of Intertrochanteric Type

Treatments

Drug: Ropivacaine
Drug: Saline

Study type

Interventional

Funder types

Other

Identifiers

NCT01119209
S-VF-20060072 - trochanteric

Details and patient eligibility

About

Reducing pain is an essential factor for early mobilization after osteosynthesis of intertrochanteric fractures. Systemic opioids have side effects that might obstruct mobilization and induce delirium and nausea. The investigators hypothesized that wound infiltration results in reduction in systemic opioid usage and pain relief without side effects.

Enrollment

74 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Intertrochanteric hip fracture

  • Fracture due to low energy trauma

  • Ability to understand danish and give informed consent

  • Ability to walk before trauma

  • Indication for osteosynthesis

    •≥ 8 in OMC (Orientation-Memory-Concentration) test with a possible maximum of 28 points

  • Informed consent

Exclusion criteria

  • Drug or medical abuse
  • Drug intolerance
  • Pathological fractures
  • Inflammatory arthritis
  • Patient included in the study with the contralateral hip

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

74 participants in 2 patient groups, including a placebo group

Ropivacaine
Active Comparator group
Treatment:
Drug: Saline
Drug: Ropivacaine
Saline
Placebo Comparator group
Treatment:
Drug: Saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems